Status:
RECRUITING
Intent of Surgery for IPMN
Lead Sponsor:
NYU Langone Health
Conditions:
Intraductal Papillary Mucinous Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This multicenter retrospective observational cohort study seeks to: 1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion o...
Eligibility Criteria
Inclusion
- All patients (18 years old of greater) who underwent surgical resection for IPMN (including low-, high-grade dysplasia, or invasive carcinoma) between July 1, 2015 and July 1, 2025.
Exclusion
- Patients with concomitant pancreatic ductal adenocarcinoma (PDAC)
Key Trial Info
Start Date :
September 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT07216521
Start Date
September 15 2025
End Date
December 1 2025
Last Update
October 14 2025
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054
2
Johns Hopkins University
Baltimore, Maryland, United States, 21287
3
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
4
Mayo Clinic
Rochester, Minnesota, United States, 55905